ARTICLE | Clinical News
Eniluracil: Phase I suspended enrollment
November 24, 2008 8:00 AM UTC
Adherex said it has temporarily suspended enrollment in a U.S. Phase I trial after a reprioritization of its development programs. The trial, which has enrolled 41 patients, is evaluating oral enilura...